| Amyloid β-peptide is produced by cultured cells during normal metabolism C Haass, MG Schlossmacher, AY Hung, C Vigo-Pelfrey, A Mellon, ... Nature 359 (6393), 322-325, 1992 | 2736 | 1992 |
| Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids P Seubert, C Vigo-Pelfrey, F Esch, M Lee, H Dovey, D Davis, S Sinha, ... Nature 359 (6393), 325-327, 1992 | 2393 | 1992 |
| Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease JP Anderson, DE Walker, JM Goldstein, R De Laat, K Banducci, ... Journal of Biological Chemistry 281 (40), 29739-29752, 2006 | 1592 | 2006 |
| Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease H Shimura, MG Schlossmacher, N Hattori, MP Frosch, A Trockenbacher, ... Science 293 (5528), 263-269, 2001 | 1386 | 2001 |
| Dopamine covalently modifies and functionally inactivates parkin MJ LaVoie, BL Ostaszewski, A Weihofen, MG Schlossmacher, DJ Selkoe Nature medicine 11 (11), 1214-1221, 2005 | 828 | 2005 |
| Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease OMA El‐Agnaf, SA Salem, KE Paleologou, MD Curran, MJ Gibson, ... The FASEB journal 20 (3), 419-425, 2006 | 802 | 2006 |
| beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. C Haass, AY Hung, MG Schlossmacher, DB Teplow, DJ Selkoe Journal of Biological Chemistry 268 (5), 3021-3024, 1993 | 716 | 1993 |
| α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study B Mollenhauer, JJ Locascio, W Schulz-Schaeffer, F Sixel-Döring, ... The Lancet Neurology 10 (3), 230-240, 2011 | 714 | 2011 |
| Molecular markers of early Parkinson's disease based on gene expression in blood CR Scherzer, AC Eklund, LJ Morse, Z Liao, JJ Locascio, D Fefer, ... Proceedings of the National Academy of Sciences 104 (3), 955-960, 2007 | 595 | 2007 |
| Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease T Tokuda, SA Salem, D Allsop, T Mizuno, M Nakagawa, MM Qureshi, ... Biochemical and biophysical research communications 349 (1), 162-166, 2006 | 511 | 2006 |
| Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ... Experimental neurology 213 (2), 315-325, 2008 | 452 | 2008 |
| Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies MG Schlossmacher, MP Frosch, WP Gai, M Medina, N Sharma, L Forno, ... The American journal of pathology 160 (5), 1655-1667, 2002 | 415 | 2002 |
| Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo M Periquet, T Fulga, L Myllykangas, MG Schlossmacher, MB Feany Journal of Neuroscience 27 (12), 3338-3346, 2007 | 414 | 2007 |
| Acid β‐glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α‐synuclein processing V Cullen, SP Sardi, J Ng, YH Xu, Y Sun, JJ Tomlinson, P Kolodziej, I Kahn, ... Annals of neurology 69 (6), 940-953, 2011 | 375 | 2011 |
| Deciphering the role of heterozygous mutations in genes associated with parkinsonism C Klein, K Lohmann-Hedrich, E Rogaeva, MG Schlossmacher, AE Lang The Lancet Neurology 6 (7), 652-662, 2007 | 359 | 2007 |
| CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy SP Sardi, J Clarke, C Kinnecom, TJ Tamsett, L Li, LM Stanek, MA Passini, ... Proceedings of the National Academy of Sciences 108 (29), 12101-12106, 2011 | 354 | 2011 |
| Multiple system atrophy: a primary oligodendrogliopathy GK Wenning, N Stefanova, KA Jellinger, W Poewe, MG Schlossmacher Annals of Neurology: Official Journal of the American Neurological …, 2008 | 347 | 2008 |
| Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo V Cullen, M Lindfors, J Ng, A Paetau, E Swinton, P Kolodziej, H Boston, ... Molecular brain 2, 1-17, 2009 | 331 | 2009 |
| Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures M Hakimi, T Selvanantham, E Swinton, RF Padmore, Y Tong, G Kabbach, ... Journal of neural transmission 118, 795-808, 2011 | 329 | 2011 |
| Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers PP Pramstaller, MG Schlossmacher, TS Jacques, F Scaravilli, C Eskelson, ... Annals of neurology 58 (3), 411-422, 2005 | 324 | 2005 |
